Comparing tumor antigen specificity of lysate versus peptide-pulsed dendritic cell-based vaccines

被引：0
|
作者：
Maine, GN [1 ]
Mulé, JJ [1 ]
机构：
[1] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA
来源：
FASEB JOURNAL | 2002年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A334 / A334
页数：1
相关论文
共 50 条
  • [31] Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines
    Jurjen M. Ruben
    Willemijn van den Ancker
    Hetty J. Bontkes
    Theresia M. Westers
    Erik Hooijberg
    Gert J. Ossenkoppele
    Tanja D. de Gruijl
    Arjan A. van de Loosdrecht
    Cancer Immunology, Immunotherapy, 2014, 63 : 335 - 345
  • [32] Overview of tumor cell-based vaccines
    Copier, John
    Dalgleish, Angus
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2006, 25 (5-6) : 297 - 319
  • [33] Dietary celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer
    Hahn, T
    Alvarez, I
    Ramanathapuram, L
    Dial, S
    Akporiaye, E
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S22 - S23
  • [34] Control of tumor outgrowth by regional immunization with peptide-pulsed dendritic cells depends on epitope density
    Mullins, DW
    Bullock, TNJ
    Sheasley, SL
    Engelhard, VH
    FASEB JOURNAL, 2002, 16 (04): : A334 - A334
  • [35] Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
    Nestle, FO
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S25 - S25
  • [36] Peptide-pulsed MHC class II mutant dendritic cell vaccine has superior efficacy in a murine tumor model
    Seishima, Noriko
    Olkhanud, Purevdorj B.
    Becker, William
    Maeng, Hoyoung
    Lopez-Lago, Miguel
    Wiseman, Charles
    Williams, William V.
    Berzofsky, Jay A.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [37] Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL
    Luketic, Lea
    Delanghe, Jordan
    Sobol, Paul T.
    Yang, Pingchang
    Frotten, Erin
    Mossman, Karen L.
    Gauldie, Jack
    Bramson, Jonathan
    Wan, Yonghong
    JOURNAL OF IMMUNOLOGY, 2007, 179 (08): : 5024 - 5032
  • [38] Dendritic cell based tumor vaccines
    Nouri-Shirazi, M
    Banchereau, J
    Fay, J
    Palucka, K
    IMMUNOLOGY LETTERS, 2000, 74 (01) : 5 - 10
  • [39] Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
    Nestle, FO
    Alijagic, S
    Gilliet, M
    Sun, YS
    Grabbe, S
    Dummer, R
    Burg, G
    Schadendorf, D
    NATURE MEDICINE, 1998, 4 (03) : 328 - 332
  • [40] Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell Vaccines
    Yamaguchi, Shinjiro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    Sakamori, Ryotaro
    Uemura, Akio
    Mizushima, Tsunekazu
    Ohkawa, Kazuyoshi
    Storkus, Walter J.
    Hayashi, Norio
    CANCER, 2007, 110 (07) : 1469 - 1477
12345